Pictet Asset Management Ltd. raised its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 4.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 96,066 shares of the medical device company’s stock after buying an additional 4,038 shares during the period. Pictet Asset Management Ltd.’s holdings in Cooper Companies, Inc. (The) were worth $21,014,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of COO. Teachers Advisors LLC boosted its position in shares of Cooper Companies, Inc. (The) by 17.5% in the fourth quarter. Teachers Advisors LLC now owns 61,032 shares of the medical device company’s stock valued at $10,676,000 after buying an additional 9,089 shares in the last quarter. Chevy Chase Trust Holdings Inc. boosted its position in shares of Cooper Companies, Inc. (The) by 3.6% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 42,369 shares of the medical device company’s stock valued at $8,469,000 after buying an additional 1,455 shares in the last quarter. Creative Planning boosted its position in shares of Cooper Companies, Inc. (The) by 4.5% in the first quarter. Creative Planning now owns 1,893 shares of the medical device company’s stock valued at $378,000 after buying an additional 81 shares in the last quarter. Gulf International Bank UK Ltd boosted its position in shares of Cooper Companies, Inc. (The) by 2.1% in the first quarter. Gulf International Bank UK Ltd now owns 14,831 shares of the medical device company’s stock valued at $2,964,000 after buying an additional 300 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in shares of Cooper Companies, Inc. (The) by 11.6% in the first quarter. Bank of Montreal Can now owns 32,885 shares of the medical device company’s stock valued at $6,573,000 after buying an additional 3,414 shares in the last quarter. 99.97% of the stock is owned by institutional investors.

Shares of Cooper Companies, Inc. (NYSE COO) opened at 240.92 on Friday. The firm has a market cap of $11.77 billion, a P/E ratio of 36.12 and a beta of 0.61. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39. The firm’s 50-day moving average price is $245.14 and its 200 day moving average price is $214.89.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.25 by $0.25. The firm had revenue of $522.40 million during the quarter, compared to the consensus estimate of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.05 EPS. Analysts predict that Cooper Companies, Inc. will post $9.63 EPS for the current year.

The firm also recently disclosed a semiannual dividend, which was paid on Monday, August 7th. Shareholders of record on Friday, July 21st were paid a $0.03 dividend. The ex-dividend date was Wednesday, July 19th. This represents a yield of 0.02%. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is presently 0.90%.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.watchlistnews.com/pictet-asset-management-ltd-increases-stake-in-cooper-companies-inc-the-nysecoo/1477120.html.

COO has been the subject of several research reports. Zacks Investment Research raised shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 price target for the company in a research note on Wednesday, May 3rd. Stifel Nicolaus raised their price target on shares of Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, June 2nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $250.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Saturday, June 3rd. Oppenheimer Holdings, Inc. set a $225.00 price target on shares of Cooper Companies, Inc. (The) and gave the stock a “hold” rating in a research note on Saturday, June 3rd. Finally, BMO Capital Markets reaffirmed an “outperform” rating and set a $255.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Cooper Companies, Inc. (The) currently has a consensus rating of “Buy” and an average target price of $242.00.

In other Cooper Companies, Inc. (The) news, CEO Paul L. Remmell sold 9,294 shares of the company’s stock in a transaction on Friday, July 14th. The stock was sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the transaction, the chief executive officer now owns 6,186 shares in the company, valued at approximately $1,536,973.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Randal Golden sold 1,621 shares of the company’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total value of $394,956.65. Following the completion of the transaction, the vice president now owns 1,731 shares of the company’s stock, valued at approximately $421,758.15. The disclosure for this sale can be found here. Insiders sold a total of 67,331 shares of company stock valued at $16,400,454 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.